Incanthera's Series A Round

Incanthera raised a round of funding on February 02, 2014.

Incanthera is an oncology company with a unique pipeline of technologies that target tumors. The lead cancer therapeutic opportunity is a new chemical entity called ICT2588, which has been designed to…

Articles about Incanthera's Series A Round: